Windtree Therapeutics (WINT) Short Interest Ratio & Short Volume $1.19 +0.14 (+13.33%) Closing price 04:00 PM EasternExtended Trading$1.19 +0.00 (+0.08%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Windtree Therapeutics Short Interest DataWindtree Therapeutics (WINT) has a short interest of 161,600 shares, representing 4.43% of the float (the number of shares available for trading by the public). This marks a -82.63% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 3.20 million shares to cover all short positions.Current Short Interest161,600 sharesPrevious Short Interest930,100 sharesChange Vs. Previous Month-82.63%Dollar Volume Sold Short$83.40 thousandShort Interest Ratio1.2 Days to CoverLast Record DateJune 30, 2025Outstanding Shares3,660,000 sharesShort Percent of Float4.43%Today's Trading Volume19,254,456 sharesAverage Trading Volume3,195,338 sharesToday's Volume Vs. Average603% Short Selling Windtree Therapeutics? Sign up to receive the latest short interest report for Windtree Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartWINT Short Interest Over TimeWINT Days to Cover Over TimeWINT Percentage of Float Shorted Over Time Windtree Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025161,600 shares $83.40 thousand -82.6%4.4%1.2 $0.52 6/15/2025930,100 shares $550.62 thousand +411.0%25.5%0.3 $0.59 5/31/2025182,000 shares $142.52 thousand +70.4%24.3%0 $0.78 5/15/2025106,800 shares $88.64 thousand +110.2%14.3%0 $0.83 4/30/202550,800 shares $59.44 thousand -23.6%6.8%0 $1.17 4/15/202566,500 shares $78.47 thousand -76.2%8.9%0 $1.18 3/31/2025279,300 shares $351.92 thousand +466.5%37.3%0.1 $1.26 3/15/202549,300 shares $101.07 thousand -40.6%6.6%0 $2.05 2/28/202583,000 shares $263.94 thousand +44.9%11.1%0.3 $3.18 2/15/202557,300 shares $393.65 thousand -67.1%7.7%0.4 $6.87 Get the Latest News and Ratings for WINT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Windtree Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2025174,100 shares $22.74 thousand -80.9%1.6%0 $0.13 1/15/2025909,000 shares $220.89 thousand +72.4%8.3%0.3 $0.24 12/31/2024527,200 shares $184.15 thousand +6.1%5.9%0.2 $0.35 12/15/2024497,000 shares $175.64 thousand +228.5%5.6%0.3 $0.35 11/30/2024151,300 shares $80.26 thousand +389.6%1.7%0.1 $0.53 11/15/202430,900 shares $14.68 thousand -84.2%0.4%0 $0.48 10/31/2024195,700 shares $137.66 thousand +301.9%2.4%0.1 $0.70 10/15/202448,700 shares $32.14 thousand -50.7%1.4%0 $0.66 9/30/202498,700 shares $235.89 thousand +174.9%2.8%0.1 $2.39 9/15/202435,900 shares $113.80 thousand -65.9%2.6%0 $3.17 8/31/2024105,400 shares $854.79 thousand -6.8%23.9%0.1 $8.11 8/15/2024113,100 shares $1.26 million -56.8%25.6%0.1 $11.14 7/31/2024261,700 shares $2.39 million +455.6%59.3%0.3 $9.12 7/15/202447,100 shares $174.27 thousand -17.5%10.7%1.5 $3.70 6/30/202457,100 shares $183.29 thousand +21.2%12.9%1.8 $3.21 6/15/202447,100 shares $146.01 thousand +20.8%10.7%1.7 $3.10 5/31/202439,000 shares $138.06 thousand +89.3%9.1%1.6 $3.54 5/15/202420,600 shares $94.78 thousand +62.2%4.8%0.8 $4.60 4/30/202412,700 shares $63.88 thousand +388.5%3.0%0.6 $5.03 4/15/20242,600 shares $19.66 thousand -93.5%N/A0.2 $7.56 3/31/202439,700 shares $14.05 thousand +30.2%0.5%0.2 $0.35 3/15/202430,500 shares $10.37 thousand -47.8%0.4%0.1 $0.34 2/29/202458,400 shares $21.02 thousand -42.2%0.8%0.2 $0.36 2/15/2024101,100 shares $36.09 thousand -56.0%1.9%0.3 $0.36 1/31/2024229,600 shares $96.50 thousand +353.8%5.3%0.8 $0.42 1/15/202450,600 shares $28.95 thousand +25.6%1.0%0.2 $0.57 12/31/202340,300 shares $28.98 thousand +108.8%N/A0.3 $0.72 12/15/202319,300 shares $14.09 thousand -55.5%0.5%0.2 $0.73 11/30/202343,400 shares $50.34 thousand -13.4%1.1%0.4 $1.16 11/15/202350,100 shares $46.08 thousand -22.5%1.2%0.5 $0.92This Could Be the Most Profitable Season of Your Life (Ad)Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending. Join The Crypto Code Workshop + get $10 in Bitcoin for attending 10/31/202364,600 shares $67.83 thousand -65.8%1.5%0.5 $1.05 10/15/2023188,900 shares $236.13 thousand +540.3%4.3%1.5 $1.25 9/30/202329,500 shares $27.98 thousand +81.0%0.7%0.2 $0.95 9/15/202316,300 shares $18.75 thousand +27.3%0.4%0.1 $1.15 8/31/202312,800 shares $14.10 thousand -75.8%2.0%0.1 $1.10 8/15/202352,800 shares $85.54 thousand +294.0%7.9%0.2 $1.62 7/31/202313,400 shares $18.63 thousand +162.8%2.0%0 $1.39 7/15/20235,100 shares $6.83 thousand -42.1%N/A0 $1.34 6/30/20238,800 shares $11 thousand -90.5%N/A0 $1.25 6/15/202392,500 shares $142.45 thousand -2.9%N/A0.1 $1.54 5/31/202395,300 shares $121.98 thousand -51.2%N/A0.1 $1.28 5/15/2023195,100 shares $290.70 thousand +64.4%N/A0.2 $1.49 4/30/2023118,700 shares $194.67 thousand +136.9%68.7%0.1 $1.64 4/15/202350,100 shares $219.44 thousand +87.6%8.5%0.1 $4.38 3/31/202326,700 shares $133.23 thousand -2.9%4.7%0.2 $4.99 3/15/202327,500 shares $132.55 thousand -53.0%4.9%0.3 $4.82 2/28/202358,500 shares $367.38 thousand +604.8%10.3%0.6 $6.28 2/15/20238,300 shares $1.23 thousand -98.9%N/A0.1 $0.15 1/31/2023754,800 shares $120.77 thousand +16.1%N/A1.4 $0.16 1/15/2023650,300 shares $143.03 thousand -28.2%N/A1.3 $0.22 12/30/2022905,900 shares $154.00 thousand -28.7%N/A2 $0.17 12/15/20221,270,000 shares $226.06 thousand +4.1%N/A1.4 $0.18 11/30/20221,220,000 shares $234.85 thousand -3.2%N/A1.3 $0.19 11/15/20221,260,000 shares $110.25 thousand -9.4%5.3%1.2 $0.09 10/31/20221,390,000 shares $238.39 thousand -10.9%7.4%0.7 $0.17 10/15/20221,560,000 shares $379.70 thousand +26.8%8.3%0.8 $0.24 9/30/20221,230,000 shares $369.12 thousand +44.6%6.5%0.7 $0.30 9/15/2022850,900 shares $314.66 thousand -8.3%4.5%0.6 $0.37 8/31/2022928,000 shares $365.63 thousand +21.9%5.1%0.7 $0.39 8/15/2022761,500 shares $288.61 thousand +0.0%4.2%0.6 $0.38 7/31/2022761,200 shares $299.91 thousand -19.9%4.3%3.1 $0.39 7/15/2022950,700 shares $384.56 thousand +6.8%5.4%3.4 $0.40 6/30/2022890,200 shares $371.21 thousand +3.6%5.1%1.1 $0.42 6/15/2022858,900 shares $365.03 thousand -7.5%4.9%1.1 $0.43 5/31/2022928,500 shares $452.18 thousand +18.9%5.4%1.2 $0.49 5/15/2022781,200 shares $429.66 thousand -12.1%4.5%1.1 $0.55 4/30/2022888,700 shares $657.28 thousand +104.6%5.3%1.3 $0.74 4/15/2022434,400 shares $462.68 thousand -0.5%2.6%0.6 $1.07 3/31/2022436,400 shares $497.50 thousand -9.1%2.6%3.9 $1.14 3/15/2022480,100 shares $458.50 thousand +10.4%2.9%3.4 $0.96 2/28/2022434,800 shares $465.24 thousand -21.0%2.6%3.1 $1.07 2/15/2022550,600 shares $578.13 thousand +60.9%3.3%3.4 $1.05 1/31/2022342,200 shares $386.69 thousand -30.6%2.0%1.9 $1.13 1/15/2022493,000 shares $734.57 thousand +3.1%2.9%2.5 $1.49 12/31/2021478,000 shares $769.58 thousand -19.7%2.8%1.8 $1.61 12/15/2021595,400 shares $940.73 thousand -12.9%3.5%1.7 $1.58 11/30/2021683,600 shares $1.17 million -5.3%4.2%2 $1.71 11/15/2021721,900 shares $1.24 million -15.1%4.5%2 $1.72 10/29/2021849,800 shares $1.51 million -21.3%5.6%2.2 $1.78 10/15/20211,080,000 shares $2.46 million +6.9%6.9%1.6 $2.28This Could Be the Most Profitable Season of Your Life (Ad)Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending. Join The Crypto Code Workshop + get $10 in Bitcoin for attending 9/30/20211,010,000 shares $2.08 million -18.6%6.5%1.6 $2.06 9/15/20211,240,000 shares $2.26 million -0.8%8.0%2.1 $1.82 8/31/20211,250,000 shares $2.45 million -27.3%8.1%1.8 $1.96 8/13/20211,720,000 shares $3.13 million +10.3%11.2%0.6 $1.82 7/30/20211,560,000 shares $2.95 million +1.3%19.8%0.5 $1.89 7/15/20211,540,000 shares $2.82 million -1.9%19.5%0.5 $1.83 6/30/20211,570,000 shares $3.60 million +6.1%19.9%0.5 $2.29 6/15/20211,480,000 shares $3.37 million +108.2%18.8%0.5 $2.28 5/28/2021710,900 shares $1.26 million +10.8%9.0%0.2 $1.77 5/14/2021641,500 shares $1.08 million +95.6%8.1%0.9 $1.68 4/30/2021328,000 shares $734.72 thousand +35.9%4.7%0.7 $2.24 4/15/2021241,400 shares $555.22 thousand +87.1%3.5%0.6 $2.30 3/31/2021129,000 shares $276.06 thousand -18.2%3.9%0.4 $2.14 3/15/2021157,600 shares $660.34 thousand +81.4%4.6%1 $4.19 2/26/202186,900 shares $438.41 thousand +1.6%2.5%1.8 $5.05 2/12/202185,500 shares $469.40 thousand -3.9%2.5%3.6 $5.49 1/29/202189,000 shares $501.07 thousand -0.8%2.6%5 $5.63 1/15/202189,700 shares $554.35 thousand No Change2.6%6.5 $6.18 WINT Short Interest - Frequently Asked Questions What is Windtree Therapeutics' current short interest? Short interest is the volume of Windtree Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 161,600 shares of WINT short. 4.43% of Windtree Therapeutics' shares are currently sold short. Learn More on Windtree Therapeutics' current short interest. What is a good short interest ratio for Windtree Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. WINT shares currently have a short interest ratio of 1.0. Learn More on Windtree Therapeutics's short interest ratio. What is a good short interest percentage for Windtree Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.43% of Windtree Therapeutics' floating shares are currently sold short. Is Windtree Therapeutics' short interest increasing or decreasing? Windtree Therapeutics saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 161,600 shares, a drop of 82.6% from the previous total of 930,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Windtree Therapeutics' short interest compare to its competitors? 4.43% of Windtree Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Windtree Therapeutics: Trinity Biotech PLC (4.33%), NKGen Biotech, Inc. (1.16%), Flora Growth Corp. (1.57%), 23andMe Holding Co. (11.90%), Athira Pharma, Inc. (3.94%), AlloVir, Inc. (2.56%), Sonnet BioTherapeutics Holdings, Inc. (1.32%), NextCure, Inc. (1.40%), Leap Therapeutics, Inc. (9.27%), IM Cannabis Corp. (12.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Windtree Therapeutics stock? Short selling WINT is an investing strategy that aims to generate trading profit from Windtree Therapeutics as its price is falling. WINT shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Windtree Therapeutics? A short squeeze for Windtree Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of WINT, which in turn drives the price of the stock up even further. How often is Windtree Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WINT, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies TRIB Short Interest NKGN Short Interest FLGC Short Interest ME Short Interest ATHA Short Interest ALVR Short Interest SONN Short Interest NXTC Short Interest LPTX Short Interest IMCC Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:WINT) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Windtree Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Windtree Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
